This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Microcap Article: Archive
Zacks Initiates Coverage of Kingsway With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Kingsway as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore KWY's disciplined dealmaking and operational execution amid integration and capital risks.
KWYPositive Net Change
finance insurance
Zacks June View on Equity Markets
by John Blank
The significant expansion of ROIC for both Computer-Office Equipment and Electronics from 2020 to today is a classic case of structural tech tailwinds.
asset-allocation
ZRS Chart of the Month
by John Blank
Info Tech (7.91) and Industrials (6.39) are very overpriced, based on current valuations. They are +39% and +35% over their medians, respectively.
asset-allocation
June Asset Allocation Guidelines
by John Blank
Five different frameworks specify portfolio risk tolerance: from Risky "Max Growth" to Conservative "Income." Choose one that fits you.
asset-allocation
June Sell-Side and Buy-Side Consensus at a Glance
by John Blank
A valuation boost from the attraction of a broad equity risk premium does NOT appear, using Zacks 2026 S&P500 earnings of $318.48.
asset-allocation
International: Update on Global Regions
by John Blank
For companies that generate more than 50% of sales outside the U.S., the blended earnings growth rate is 20.8%.
asset-allocation
Zacks Initiates Coverage of Douglas Elliman With Underperform Recommendation
by Debanjana Dey
Discover why Zacks rates Douglas Elliman as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore DOUG's mounting pressure from weak housing activity, widening losses and legal costs.
DOUGNegative Net Change
finance real-estate
Cumberland's Ifetroban Shows Potential to Limit Metastasis
by Zacks Equity Research
CPIX reports positive Phase 2a results for Ifetroban, showing a favorable safety profile and promising early signs of reducing cancer metastasis in high-risk patients.
CPIXPositive Net Change
medical
2 Small Caps with Recurring Revenue and Strong Balance Sheets
by Mark Zinski
DJCO and IDT are diversifying away from legacy businesses with higher margin recurring revenue streams.
IDTNegative Net Change DJCOPositive Net Change
small-cap
Zacks Initiates Coverage of TOON With Underperform Recommendation
by Urbashi Dutta
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates Kartoon Studios as "Underperform." Explore how TOON's discounted valuation is overshadowed by losses, dilution risks, funding concerns and an uncertain path to profitability.
TOONNegative Net Change
consumer-discretionary